HMB and Exercise-induced Muscle Damage
Supplementation, Sport, Sports Nutrition

About this trial
This is an interventional treatment trial for Supplementation
Eligibility Criteria
Inclusion Criteria:
- written informed consent from all participants before the study
- a current medical clearance to practice sports,
- training experience: at least 1 year strength training programs that include lower limbs,
- minimum of 3 workout sessions (strength/resistance training) a week,
- protein intake in customary diet and during the study protocol > 1.6g / kg of body mass per day,
- individual maximum strength greater than 2.5 times the body weight for the 1RM test in the leg-press.
Exclusion Criteria:
- current injury,
- any health-related contraindication,
- declared general feeling of being unwell,
- unwilling to follow the study protocol,
- serious disease or metabolic problems,
- intake of creatine, caffeine or beta-alanine, or other ergogenic supplements 3 months before the beginning of the study,
- history of anabolic androgenic steroids or drugs use that may interfere with muscle mass control (eg, corticosteroids), or affect physical performance,
- smoking and tobacco use,
- presence of infectious disease in the previous 4 weeks of the study.
Sites / Locations
- Escola de Educação Física e Esporte da USP / School of Physical Education and Sport - USP.Recruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
HMB supplementation
Placebo treatment
The experimental procedure for each participant in this group includes a one week HMB supplementation. HMB will be administered in the form of blinded capsules containing 0.5 g HMB per capsule. The capsules will be ingested with at least 250 mL of water. Each athlete will ingest 8 capsules (4 x 2 capsules) of HMB in a split dose per day. On training days the supplements will be taken in the morning (2 capsules), 1.5 hours before training session (2 capsules), immediately after training (2 capsules) and before sleep (2 capsules). On rest days the supplements will be taken in the morning (2 capsules), around midday (2 capsules), in the afternoon (2 capsules) and before bedtime (2 capsules) at possibly similar (approx. 4 hours) intervals during the day.
The experimental procedure for each participant in this group includes a one-week placebo (PLA) administration. PLA (corn starch) will be placed in the blinded capsules form. PLA will be ingested with at least 250 mL of water. Each participant in this group will ingest 8 placebo capsules a day. On training days the PLA capsules will be taken in the morning (2 capsules), 1.5 hours before training session (2 capsules), immediately after training (2 capsules) and before sleep (2 capsules). On rest days the supplements will be taken in the morning (2 capsules), around midday (2 capsules), in the afternoon (2 capsules) and before bedtime (2 capsules) at possibly similar (approx. 4 hours) intervals.